Data protection Impressum

Life sciences

Burgdorf-based medtech Ypsomed has announced the sale of its diabetes care business to TecMed AG for up to CHF 420 million. The move marks a significant strategic shift, positioning Ypsomed as a pure-play provider of self-injection systems for pharmaceutical and biotech partners worldwide.

Bern-based Ypsomed pivots with CHF 420 million diabetes unit sale to TecMed

23 April 2025

A collaborative research team from EPFL, the University of Geneva (UNIGE), and Geneva University Hospitals (HUG) has been awarded the 2025 Leenaards Science Prize for a pioneering project aimed at enhancing the effectiveness of immunotherapy by altering the mechanical properties of cancer cells.

Western Switzerland research teams explore new strategy to boost cancer immunotherapy

14 April 2025

Medtech start-up Novigenix has received EUR 1.8 million from the EU’s Innovative Health Initiative to support the industrialization of its AI-driven liquid biopsy platform as part of a major international cancer research collaboration.

Novigenix secures EUR 1.8 million to scale precision oncology platform

9 April 2025

The CHUV has officially inaugurated its new Children’s Hospital in Lausanne, consolidating pediatric care and setting a new standard for child-centered healthcare infrastructure in Western Switzerland.

CHUV’s new Children’s Hospital enhances pediatric care in Western Switzerland

8 April 2025

A new privately funded health innovation campus will take shape in Meyrin, combining clinical care, research, and industry in one integrated ecosystem.

Campus Santé, a landmark investment in Geneva’s future of healthcare and research

7 April 2025

Researchers in Bern have developed an AI-based tool that detects rare coronary artery anomalies with high precision in cardiac CT images, potentially transforming diagnostics in cardiology.

AI tool developed in Bern improves detection of rare coronary anomalies

4 April 2025

The 10th edition of BioInnovation Day gathered more than 250 life sciences stakeholders at Campus Biotech in Geneva. Two standout projects, Artiria Medical and Reverso Therapeutics, were honoured for their innovative contributions to stroke treatment and cardiovascular medicine.

Artiria Medical and Reverso Therapeutics awarded at BioInnovation Day 2025

4 April 2025

With over 30 years of presence in Le Locle, Jabil has established itself as a key player in Neuchâtel’s advanced manufacturing landscape.

Jabil, driving medical innovation from the heart of Neuchâtel’s industrial ecosystem

2 April 2025

In a significant step toward future pandemic preparedness, researchers at the University of Bern have uncovered a new mechanism by which coronaviruses manipulate human cells to replicate, offering a promising target for broad-spectrum antiviral therapies.

University of Bern researchers identify promising new strategy against coronaviruses

1 April 2025

A team of researchers from the University of Bern and Japan’s RIKEN Institute has achieved a major breakthrough in sustainable chemistry by developing a novel method to synthesize organic molecules using sodium and iron—two abundant, non-toxic metals. The innovation could pave the way for more environmentally friendly production of pharmaceuticals and fine chemicals.

The University of Bern and RIKEN develop greener chemistry for pharmaceutical production

25 March 2025

1 2 3 4 5 … 40